NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Significant Decrease in Short Interest

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the target of a large decrease in short interest in November. As of November 15th, there was short interest totalling 187,000 shares, a decrease of 75.5% from the October 31st total of 764,300 shares. Based on an average trading volume of 2,760,000 shares, the days-to-cover ratio is presently 0.1 days.

NovaBay Pharmaceuticals Stock Down 6.2 %

NBY traded down $0.04 on Wednesday, reaching $0.57. The company’s stock had a trading volume of 88,476 shares, compared to its average volume of 958,199. The company has a market capitalization of $2.40 million, a price-to-earnings ratio of -0.06 and a beta of 2.82. NovaBay Pharmaceuticals has a fifty-two week low of $0.36 and a fifty-two week high of $11.45.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.